UK’s SynbiCITE provides fund to Prokarium to develop new vaccine for chlamydia

The UK’s innovation and knowledge centre (IKC) for synthetic biology SynbiCITE has granted a fund for biotechnology firm Prokarium to use for development of a new chlamydia vaccine.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news